News search

A new CNIC-led study shows that a genetic tool derived from baker’s yeast enables human cells to manufacture the building blocks of DNA even when their mitochondria fail.

An international team has published NeuMap, the first atlas to reveal the global architecture of neutrophils, showing how this “first line of defense” reorganizes to protect, remember, and heal.

A new study led by the CNIC has identified imidazole propionate (ImP), a metabolite produced by gut bacteria, as a driver of atherosclerosis— as a driver of atherosclerosis, the disease behind most heart attacks and strokes

This new tool will advance the development of treatments for congenital muscle diseases and cardiomyopathies. 

Dr. Jonathan Kipnis is a Principal Investigator and the Alan A. and Edith L. Wolff Distinguished Professor of Pathology and Immunology at Washington University

A study led by the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), in collaboration with the Instituto de Investigación Biomédica de Barcelona (IRB Barcelona), has identified the most effective subtype of dendritic cell for generating immune memory in response to cancer

The discovery, published in Nature, opens the path to new strategies for treating skin diseases and immunological disorders, with special potential for the treatment of inflammation, diabetes, and age-related conditions

The study describes an innovative probe for the noninvasive detection of macrophages using PET technology